Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era

Diagnosis of CIN2+ decreased in women aged 18-24 years, but not in older women. Both changes in screening and human papillomavirus vaccination could have contributed to the decline of CIN2+ in young women.